FAMILY PHYSICIANS’ MANAGEMENT OF GENETIC
ASPECTS OF A CARDIAC DISEASE: A SCENARIO-BASED
STUDY FROM SLOVENIA Klemenc-Ketiš Z, Peterlin B *Corresponding Author: Assistant Professor Zalika Klemenc-Ketiš, M.D., Ph.D., Medical Faculty Maribor, Taborska 8,
2000 Maribor, Slovenia. Tel.: +386-41-516-067. Fax: +386-590-30-250. E-mail: zalika.klemenc.ketis@gmail.com page: 15
|
RESULTS
There were 271 (27.1%) FPs who completed the
questionnaire, out of which 66 (24.4%) were men and
205 (75.6%) were women (Table 1). Mean age of the
sample was 45.5 ± 10.6 years. Mean age of the men
was 50.1 ± 11.8 and mean age of the women was 43.9
± 9.7 (p <0.001). Mean working period of the sample
was 17.3 ± 11.6 years and mean time from graduation
19.6 ± 10.9 years. Mean number of patient seen by
the FP in the previous week was 213.7 ± 77.7.
When dealing with the clinical case, most FPs
expressed willingness to take Mr. Smith’s family
history. More than 70.0% of FPs would tell Mr.
Smith that it was his responsibility to tell his brother
about the genetic risk and almost 90.0% would tell
Mr. Smith to tell his brother to come to see them. In
the last case, more than 90.0% of FPs would inform
Mr. Smith’s brother about the risk by themselves
(Table 2).
Younger FPs were more inclined to give the
information to Mr. Smith (t = –2.040, p = 0.042).
Similar associations were found regarding years
from graduation (t = –2.054, p = 0.041). Younger
FPs (and those with less working years) would also
more likely respect the wish of Mr. Smith not to inform
his brother about the mutation (t = –2.112, p =
0.036; t = –2.065, p = 0.040; respectively). On the
other hand, older FPs, FPs with more working years
and with more time since graduation would inform
Mr. Smith’s brother on his next visit to the practice
(t = 3.112, p = 0.002; t = 2.823, p = 0.005; t = 2.925,
p = 0.004). Similar findings were detected also in
terms of association of age/years from graduation/
working experiences and respecting or disrespecting
the patient’s wish regarding his brother and referrals
to clinical specialists (Table 3).
|
|
|
|
|
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|